Bio-Rad Laboratories, Inc. designs, manufactures, and distributes a broad range of innovative
tools and services to the life science research and clinical diagnostics markets. Founded in 1952,
Bio-Rad has a global team of more than 7,750 employees and serves more than 100,000 research
and industry customers worldwide through the company’s global network of operations.
For 30 years, Miltenyi Biotec has been dedicated to improving scientific understanding and
medical progress for clinical research and cell and gene therapy (CGT). Our products and services
facilitate the advancement of science in these key areas, and support clinicians who are bringing
new cellular therapies to reality. We specialize in developing tailored cell processing protocols
for the fully automated and closed, GMP-compliant CliniMACS Prodigy®. In addition, we offer
comprehensive CGT support, including contract development and manufacturing of CGT products
and tailored GMP lentiviral vectors.
Every day, QIAGEN serves 500,000 customers globally, all seeking insights from the building blocks of life – DNA and RNA. Delivering Sample to Insight solutions for molecular testing, we help scientists and clinicians to make breakthroughs in life sciences research, molecular diagnostics and drug development. In healthcare and academia, and for drug-discovery and forensic laboratories, our innovative solutions turn samples (DNA from blood, tissue, …) into insights (genetic clues for markers and medicines). Automated end-to-end solutions cover sample processing, assay development, bioinformatics software and knowledge bases for analysis. These seamless, cost-effective workflows improve disease detection and enable precision medicine, making improvements in life possible.
Halo Labs knows aggregates and particles. The Aura can count and characterize subvisible particles and tell you if they are aggregated drug product, excipients, or external contaminants. A simple, plate-based approach enables low-volume, high-throughput, fully automated particle imaging and analysis at any stage from developability assessment through quality control.
As the possibilities of cellular therapy continue to expand by the day, you need a single solution that can manage all the changing requirements around data, reporting, and process. In addition, the growing use of CAR-T and other novel therapies means new data management challenges for both clinics and labs. WellSky Biotherapies software provides the solution with complete workflow management for both clinical and manufacturing programs. That means improved visibility into processes, on-demand analytics, and streamlined service coordination.
Want to evaluate killing kinetics with physiologically relevant effector cell to target cell ratios? Concerned about the possible confounding effects of labeling your cells? Introducing Maestro ZHT from Axion BioSystems, the world’s most advanced impedance-based real-time cell analysis platform. Over minutes or weeks gain unprecedented access to the kinetics of your biology. Straightforward and easy to use, any researcher can now track immune cell-mediated killing in 96- and 384-well plates.
therapy development with its Tapestri Platform, powered by single-cell multi-omics. Discover how Tapestri enables accurate characterization of your cell and gene therapy candidates for safer and more effective therapeutic strategies. We partner with pharma and biopharma companies across advanced therapy development programs to implement proven single-cell multi-omics capabilities into discovery, translational, and clinical research efforts.